CoChat

Glycogen synthase kinase‐3β and tau genes interact in Alzheimer's disease

Kwok, John B. J., Loy, Clement T., Hamilton, Gillian, Lau, Edmond, Hallupp, Marianne, Williams, Julie, Owen, Michael J., Broe, G. Anthony, Tang, Nelson, Lam, Linda, Powell, John F., Lovestone, Simon, Schofield, Peter R. · 2008 · Annals of Neurology
Cited by 78

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Objective: We examined the epistatic effect between haplotypes of glycogen synthase kinase‐3 β (GSK3B) gene and microtubule‐associated protein Tau (MAPT) gene in Alzheimer's disease (AD). Methods: A genetic association study of three AD cohorts was made. Linear regression analyses were used to examine effects of MAPT polymorphisms on gene expression and alternative splicing. β‐Catenin levels and signaling were determined using Western blot and luciferase reporter assays in cells transfected with a combination of GSK3B and MAPT complementary DNA. Results: Consistent interaction between GSK3B and MAPT genes in three late‐onset AD cohorts was observed, with the GSK3B haplotype (T‐T) significantly increasing the risk for AD in individuals with at least one H2 haplotype (odds ratio, 1.68–2.33; p = 0.005–0.036). The GSK3B haplotype was significantly protective in the Chinese cohort (odds ratio, 0.33; p = 0.016), after adjusting for the effect of age and sex. There are significant differences in in vivo transcriptional efficiency between the two MAPT haplotypes (H1 and H2) as determined by measurement of cerebellar transcripts (p < 0.001). Overexpression of either MAPT or GSK3B resulted in decreased β‐catenin levels compared with a control vector (p < 0.001). Conversely, cotransfection of both of these molecules increased β‐catenin signaling. Interpretation: Our genetic and biochemical analyses have identified a novel interaction between Tau and GSK‐3β in late‐onset AD causative factors. Our data are consistent with an epistatic model of interaction where discordant levels of GSK3B and MAPT gene expression can lead to altered β‐catenin levels and pathogenicity. Ann Neurol 2008

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.21476

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

Metadata

Authors
Kwok, J. B. J., Loy, C. T., Hamilton, G., Lau, E., Hallupp, M., Williams, J., Owen, M. J., Broe, G. A., Tang, N., Lam, L., Powell, J. F., Lovestone, S., & Schofield, P. R.
Venue
Annals of Neurology
Publisher
Wiley
Published
2008-10
Volume
64
Issue
4
Pages
446-454
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W1971859296
Cited by
78
References
8
FWCI
5.23
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.